Committed to responsible pain management

Developing innovative and differentiated products for people suffering from pain

At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate-to-severe pain.

News and Press

Join the Collegium team

News and Press

  • Collegium Announces $25 Million Accelerated Share Repurchase Program

    Read More
  • Collegium to Participate in Upcoming Conferences

    Read More
  • Collegium Reports Third Quarter Fiscal 2021 Results

    Read More
  • Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

    Read More